勃起功能障碍与美国男性动脉样硬化心血管疾病预测的10年风险之间的关联:来自NHANES 2001-2004的一项基于人口的研究
Yangyang Mei1, Yiming Chen2,3, Xiaogang Wang1,2,3
1Department of Urology, Jiangyin People's Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, China.
Frontiers in endocrinology
|January 1, 2025
概括
勃起功能障碍 (ED) 与较高的动脉样硬化心血管疾病 (ASCVD) 风险得分有关. 早期ED评估可能有助于识别未来心血管事件风险的个体.
科学领域:
- 心血管医学 心血管医学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 公共卫生 公共卫生
背景情况:
- 勃起功能障碍 (ED) 通常是潜在心血管疾病 (CVD) 的早期指标.
- 关于ED和CVD之间的确切关系,存在相互矛盾的证据.
- 动脉样硬化心血管疾病 (ASCVD) 风险评分为量化心血管疾病风险提供了一个工具.
研究的目的:
- 调查ED与10年ASCVD风险评分之间的关联.
- 为了确定ED是否预测了更高的ASCVD风险.
- 探索ASCVD风险与ED患病率之间的关系.
主要方法:
- 利用了1207名参与国家健康和营养检查调查 (NHANES) (2001-2004) 的数据.
- 采用加权后勤和线性回归模型来分析ED和ASCVD风险之间的关系.
- 进行了灵敏度,子组,限制立方线 (RCS) 和接收器运行特征 (ROC) 分析,以获得可靠的结果.
主要成果:
- 勃起障碍的存在与更高的ASCVD风险得分和ASCVD风险增加有关.
- 勃起障碍的存在显著增加了ASCVD风险评分 (β:2.09) 和高ASCVD风险 (OR:2.27).
- 较高的ASCVD风险类别 (边界,中等,高) 显示ED患病率逐渐增加 (ORs从2.95到18.19不等).
- RCS分析证实了ED和ASCVD风险之间的线性关系,ASCVD风险有效预测ED (AUC:0.794).
结论:
- ED可能在ASCVD的临床表现之前几年.
- 评估ED患者的心血管状况可以促进早期识别有风险的个体.
- 在ED患者的及时心血管评估允许积极实施预防策略,以改善心血管健康.
相关概念视频
Disorders of the Male Reproductive System
314
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
314
Psychoneuroimmunology: Cardiovascular Disease
25
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
25
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
1
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
1
Assessment of the Cardiovascular System I: Subjective Data
277
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
277
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
129
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
129


